Outcome after first relapse in children with acute lymphoblastic leukemia: A report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol-Reference-Cited by-同舟云学术

Outcome after first relapse in children with acute lymphoblastic leukemia: A report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol

Published:2011-02-18 Issue:2 Volume:57 Page:210-216
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

van den Berg H.,de Groot-Kruseman H.A.,Damen-Korbijn C.M.,de Bont E.S.J.M,Schouten-van Meeteren A.Y.N.,Hoogerbrugge P.M.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22946/fullpdf

Reference32 articles.

1. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: A Therapeutic Advances in Childhood Leukemia Consortium study;Ko;J Clin Oncol,2010

2. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia;Rivera;Blood,1996

3. BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: Results of DCLSG protocol ALL-8 (1991-1996);Kamps;Leukemia,2002

4. Delayed central nervous system (CNS) radiation in childhood CNS acute lymphoblastic leukemia. Results of a pilot trial;Mandell;Cancer,1990

5. Delayed craniospinal irradiation for a first isolated central nervous relapse of acute lymphoblastic leukemia: Report on 14 cases;van den Berg;Med Pediatr Oncol,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab;Therapeutic Advances in Hematology;2023-01

2. Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era;Frontiers in Pediatrics;2022-06-23

3. An institutional audit of the use of novel drugs in pediatric oncology;Cancer Reports;2021-05-03

4. Current and emerging therapeutic approaches for T‐cell acute lymphoblastic leukaemia;British Journal of Haematology;2021-05-03

5. Acute lymphoblastic leukemia;Pediatric Blood & Cancer;2021-04-05